Company Overview of kaleo, Inc.
kaleo, Inc., a pharmaceutical company, develops and markets personal medical products for various therapeutic areas. It offers naloxone auto-injectors for the use in case of opioid overdose; and epinephrine auto-injection used to treat allergic reactions. kaleo, Inc. was formerly known as Intelliject, Inc. and changed its name to kaleo, Inc. in January 2014. The company was incorporated in 2008 and is based in Richmond, Virginia.
111 Virginia Street
Richmond, VA 23219
Founded in 2008
Key Executives for kaleo, Inc.
Co-Founder and Vice President of Product Development
Compensation as of Fiscal Year 2014.
kaleo, Inc. Key Developments
Kaléo Pharma Presents at Boston Biotech NY/NJ CEO Conference, Nov-12-2014 11:25 AM
Oct 27 14
Kaléo Pharma Presents at Boston Biotech NY/NJ CEO Conference, Nov-12-2014 11:25 AM. Venue: Apella, 450 East 29th Street, New York, New York, United States. Speakers: Spencer Williamson.
Kaleo Announces $150 Million Debt Financing to Support Commercialization of EVZIO(TM)
Apr 7 14
Kaleo announced that it has entered into a $150 million debt facility with PDL BioPharma to enable kaleo to support commercialization of EVZIO(TM)(naloxone hydrochloride injection) and development of key pipeline products. Under the financing, PDL provided $150 million in cash at closing and will receive interest on the principal outstanding. The note is backed by royalty payments on kaleo's first product (Auvi-Q(TM) in the US and Allerject(TM) in Canada) and a portion of the net sales on its second product (EVZIO(TM)). Once the note is repaid, kaleo will resume receiving 100% of all product royalties and net sales. The funds will enable kaleo to support the commercialization of EVZIO, to invest in the development of pipeline products and repay existing debt. EVZIO is intended for the emergency treatment of known or suspected opioid overdose, as manifested by life-threatening respiratory depression. Kaleo is a pioneer in life saving products that provide for peace of mind that patients can carry in their pockets. Kaleo products are designed to become part of a patient's everyday life - always there, but invisible until needed. The products are simple to use and use voice and visual cues to assist a patient through the correct drug administration process.
kaleo, Inc. - Special Call
Apr 3 14
To discuss the U.S. Food and Drug Administration approval of EVZIO for emergency treatment of opioid overdose
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries